Literature DB >> 27470361

MiR-433 inhibits retinoblastoma malignancy by suppressing Notch1 and PAX6 expression.

Xiaohua Li1, Lan Yang1, Tianjiao Shuai1, Tianhua Piao1, Rui Wang2.   

Abstract

Retinoblastoma (RB) is the most frequent primary intraocular cancer. It has been demonstrated by previous studies that retinoblastoma is initiated primarily by the inactivation of the retinoblastoma Rb1 gene in retinal cells. However, additional genetic alterations than Rb1 mutation could play important roles in the process of transforming benign retinal cells into retinoblastoma tumor cells. In this study, we identified that microRNA miR-433 is one of such genetic factors. We found that the expression levels of miR-433 were downregulated in RB tissues. We also determined that miR-433 negatively regulated RB cell proliferation, migration and invasion, and induced cell cycle arrest and apoptosis of RB cells. We used bioinformatics method to predict and confirmed that Notch1 and PAX6 were miR-433 target genes in RB cells. Importantly, we demonstrated that restoration of Notch1 and PAX6 expression partially rescued the inhibition of cell proliferation and metastasis induced by miR-433 overexpression, suggesting that miR-433 regulates RB cell proliferation and metastasis through suppressing the expression of Notch1 and PAX6.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  MiR-433; Notch1; PAX6; Retinoblastoma

Mesh:

Substances:

Year:  2016        PMID: 27470361     DOI: 10.1016/j.biopha.2016.05.003

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  21 in total

1.  [MiR-433 reverses chemoresistance to docetaxel by targeting Notch1 in breast cancer cells].

Authors:  Xiaolei Hu; Pingmei Huang; Jie Wang; Wan He; Pan Zhao; Guangyu Yao; Changsheng Ye
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-07-30

2.  [Construction of a lentiviral vector carrying short?hairpin RNA targeting PAX6 and its effect on proliferation of glioma U251 cells in vitro].

Authors:  Xiao-Hong Liao; Wei-Lan Yin; Fang Wang; Li-Xiang Wu; Bai-Sheng Huang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-12-20

3.  miR-433 accelerates acquired chemoresistance of gallbladder cancer cells by targeting cyclin M.

Authors:  Jianhua Yu; Weiguang Zhang; Baochun Lu; Hongwei Qian; Haijun Tang; Zhiyang Zhu; Xinggui Yuan; Peitu Ren
Journal:  Oncol Lett       Date:  2017-12-28       Impact factor: 2.967

4.  Suppression of Disheveled-Axin Domain Containing 1 (DIXDC1) by MicroRNA-186 Inhibits the Proliferation and Invasion of Retinoblastoma Cells.

Authors:  Xuanyi Che; Yuanjie Qian; Di Li
Journal:  J Mol Neurosci       Date:  2017-12-20       Impact factor: 3.444

5.  MicroRNA-433 targets AKT3 and inhibits cell proliferation and viability in breast cancer.

Authors:  Xiaolei Hu; Jie Wang; Wan He; Pan Zhao; Changsheng Ye
Journal:  Oncol Lett       Date:  2018-01-16       Impact factor: 2.967

Review 6.  Expression profiles and prognostic value of miRNAs in retinoblastoma.

Authors:  Lara Elis Alberici Delsin; Karina Bezerra Salomao; Julia Alejandra Pezuk; Maria Sol Brassesco
Journal:  J Cancer Res Clin Oncol       Date:  2018-10-22       Impact factor: 4.553

Review 7.  Biomarkers in retinoblastoma.

Authors:  Jie Sun; Hui-Yu Xi; Qing Shao; Qing-Huai Liu
Journal:  Int J Ophthalmol       Date:  2020-02-18       Impact factor: 1.779

8.  The epigenetic silencing of microRNA-433 facilitates the malignant phenotypes of non-small cell lung cancer by targeting CREB1.

Authors:  Weige Wang; Chao Feng; Wenqiang Zhang; Yong Long; Xian'en Fa
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

9.  MicroRNA-9 inhibits proliferation and progression in retinoblastoma cells by targeting PTEN.

Authors:  Manhai Gao; Zhe Cui; Dan Zhao; Shurong Zhang; Qiang Cai
Journal:  Genes Genomics       Date:  2021-06-15       Impact factor: 1.839

10.  Circular RNA hsa_circ_0000034 promotes the progression of retinoblastoma via sponging microRNA-361-3p.

Authors:  Zhe Sun; Ai Zhang; Mingyu Hou; Tao Jiang
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.